Načítá se...
Breast cancer susceptibility associated with rs1219648 (FGFR2) and postmenopausal hormone therapy use in a population-based U.S. study
OBJECTIVE: Genome-wide association studies have consistently found variants in FGFR2 to be associated with breast cancer. Recent reports suggest that postmenopausal hormone therapy use may modify the association between single nucleotide polymorphisms in FGFR2 and breast cancer risk. We assessed the...
Uloženo v:
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3549049/ https://ncbi.nlm.nih.gov/pubmed/23435034 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GME.0b013e318268ca46 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|